↓ Skip to main content

Tiotropium versus placebo for chronic obstructive pulmonary disease

Overview of attention for article published in this source, July 2012
Altmetric Badge

Mentioned by

blogs
1 blog
policy
2 policy sources
twitter
9 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
91 Dimensions

Readers on

mendeley
63 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tiotropium versus placebo for chronic obstructive pulmonary disease
Published by
John Wiley & Sons, Ltd, July 2012
DOI 10.1002/14651858.cd009285.pub2
Pubmed ID
Authors

Karner, Charlotta, Chong, Jimmy, Poole, Phillippa

Abstract

Tiotropium is an anticholinergic agent which has gained widespread acceptance as a once daily maintenance therapy for symptoms and exacerbations of stable chronic obstructive pulmonary disease (COPD). In the past few years there have been several systematic reviews of the efficacy of tiotropium, however, several new trials have compared tiotropium treatment with placebo, including those of a soft mist inhaler, making an update necessary.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Chile 1 2%
Italy 1 2%
Unknown 60 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 21%
Researcher 13 21%
Other 6 10%
Student > Postgraduate 6 10%
Student > Bachelor 5 8%
Other 19 30%
Unknown 1 2%
Readers by discipline Count As %
Medicine and Dentistry 45 71%
Pharmacology, Toxicology and Pharmaceutical Science 6 10%
Nursing and Health Professions 3 5%
Social Sciences 2 3%
Economics, Econometrics and Finance 1 2%
Other 4 6%
Unknown 2 3%